Suchen
Apimeds Pharmaceuticals US Inc
APUSZur Watchlist hinzufügen
0.900USD
+0.005+0.58%
Handelsschluss 07/02, 13:00（ET）Kurse um 15 Minuten verzögert
11.32MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Apimeds Pharmaceuticals US Inc Unternehmen
Apimeds Pharmaceuticals US, Inc., is a clinical-stage biopharmaceutical company. The Company is engaged in developing Apitox, an intradermally administered bee venom-based toxin. It is focused on developing Apitox as a potential osteoarthritis (OA) treatment for patients with knee pain who failed to respond adequately to conservative non- pharmacologic therapy and simple analgesics.
Apimeds Pharmaceuticals US Inc Informationen
BörsenkürzelAPUS
Name des UnternehmensApimeds Pharmaceuticals US Inc
IPO-datumMay 09, 2025
CEOMenon (Vin)
Anzahl der mitarbeiter2
WertpapierartOrdinary Share
GeschäftsjahresendeMay 09
Addresse100 Matawan Road
StadtMATAWAN
BörseNASDAQ OMX – NASDAQ Basic Amex
LandUnited States of America
Postleitzahl07747
Telefon18482015010
Websitehttps://www.apimedsus.com/
BörsenkürzelAPUS
IPO-datumMay 09, 2025
CEOMenon (Vin)
Führungskräfte von Apimeds Pharmaceuticals US Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Jakap Koo
Mr. Jakap Koo
Director
Director
615.38K
+89.54%
Mr. Erik C. Emerson
Mr. Erik C. Emerson
President, Director
President, Director
75.00K
--
Dr. Bennett Weintraub, Ph.D.
Dr. Bennett Weintraub, Ph.D.
Independent Director
Independent Director
--
--
Ms. Carol O'Donnell
Ms. Carol O'Donnell
Independent Director
Independent Director
--
--
Ms. Elona Kogan, Esq.
Ms. Elona Kogan, Esq.
Independent Director
Independent Director
--
--
Mr. Erick Frim
Mr. Erick Frim
Chief Financial Officer
Chief Financial Officer
--
--
Vin Menon
Vin Menon
Chief Executive Officer, Director - Designee
Chief Executive Officer, Director - Designee
--
--
Mr. Amir Dossal
Mr. Amir Dossal
Director - Designee
Director - Designee
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Jakap Koo
Mr. Jakap Koo
Director
Director
615.38K
+89.54%
Mr. Erik C. Emerson
Mr. Erik C. Emerson
President, Director
President, Director
75.00K
--
Dr. Bennett Weintraub, Ph.D.
Dr. Bennett Weintraub, Ph.D.
Independent Director
Independent Director
--
--
Ms. Carol O'Donnell
Ms. Carol O'Donnell
Independent Director
Independent Director
--
--
Ms. Elona Kogan, Esq.
Ms. Elona Kogan, Esq.
Independent Director
Independent Director
--
--
Mr. Erick Frim
Mr. Erick Frim
Chief Financial Officer
Chief Financial Officer
--
--
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Apimeds Pharmaceuticals US Inc?
Die fünf größten Anteilseigner von Apimeds Pharmaceuticals US Inc sind: Mr. Jakap Koo